Svas Biosana SpA
MIL:SVS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (3.2), the stock would be worth €8.23 (9% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 3.5 | €9 |
0%
|
| 3-Year Average | 3.2 | €8.23 |
-9%
|
| 5-Year Average | 3.4 | €8.76 |
-3%
|
| Industry Average | 8.2 | €20.96 |
+133%
|
| Country Average | 7.6 | €19.47 |
+116%
|
Forward EV/EBITDA
Today’s price vs future ebitda
| Today's Enterprise Value | EBITDA | Forward EV/EBITDA | ||
|---|---|---|---|---|
|
€59.1m
|
/ |
Jul 2025
€17m
|
= |
|
|
€59.1m
|
/ |
Dec 2025
€18.7m
|
= |
|
|
€59.1m
|
/ |
Dec 2026
€19.9m
|
= |
|
|
€59.1m
|
/ |
Dec 2027
€20.8m
|
= |
|
Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| IT |
S
|
Svas Biosana SpA
MIL:SVS
|
47.6m EUR | 3.5 | 7.1 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.8T JPY | 28.4 | 39.1 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
62.6B USD | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
30.7B CHF | 15.1 | 39.2 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
97.7B DKK | 13.3 | 25.3 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.6B USD | 14.4 | 33.1 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.7B GBP | 12.3 | 35.6 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
6B USD | 17.4 | -16.5 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
927.6B JPY | 24.9 | 52.4 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
8.3T KRW | -84.2 | -37.7 | |
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.4B USD | 14.8 | 23.2 |
Market Distribution
| Min | 0.7 |
| 30th Percentile | 5.2 |
| Median | 7.6 |
| 70th Percentile | 10.8 |
| Max | 3 328.6 |
Other Multiples
Svas Biosana SpA
Glance View
Svas Biosana SpA distributes medical appliances. The company is headquartered in Somma Vesuviana, Napoli and currently employs 367 full-time employees. The company went IPO on 2021-12-09. The firm consists of four divisions namely: Farmex division, manufactures range of gauze and cotton made products; Medical division, provides suction line, infusion line, and custom packs; Svas division, provides own brand products, specialities, galenic solutions and disposables; and Harvest division, provides electromedical equipments, after-sales technical services. The firm is the subsidiary of Svas group. Test Data.
